Analytical Data
-
基因名
C9orf19
- Application
-
别名
5730414A08Rik; C77180; C9orf19; GAPR 1; GAPR-1; GAPR1_HUMAN; GLI pathogenesis related 2; Glioma pathogenesis related Protein 2; Glioma pathogenesis-related Protein 2; GliPR 2
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H4G4
-
表达区间
1-154aa
-
氨基酸序列
MGKSASKQFHNEVLKAHNEYRQKHGVPPLKLCKNLNREAQQYSEALASTRILKHSPESSRGQCGENLAWASYDQTGKEVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKASASDGSSFVVARYFPAGNVVNEGFFEENVLPPKK
-
分子量
43.6 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf19, or chromosome 9 open reading frame 19, is a gene that has recently gained attention in genetic and molecular biology research due to its potential implications in neurological disorders and cellular functions. The protein encoded by C9orf19 is believed to be involved in a variety of cellular processes, yet its precise biological role remains largely uncharacterized. Previous studies have indicated its potential link to conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), particularly due to its association with genetic variants in affected individuals. As researchers strive to understand the molecular mechanisms underpinning these diseases, the study of C9orf19 recombinant protein has become crucial. By producing and analyzing this protein, scientists aim to elucidate its structure, function, and interactions within the cell. This research may provide insights into how C9orf19 contributes to neuronal health and disease, ultimately aiding in the development of targeted therapies. Overall, the investigation into C9orf19 recombinant protein stands at the intersection of genetic research and neurobiology, highlighting its potential role as a biomarker or therapeutic target for neurodegenerative diseases.
